CMS

First‑half 2026 earnings surge in securities firms as self‑trading fuels 40%+ revenue growth, ESG and fixed‑income expansion boost value and shareholder returns.

China’s 2026 financial outlook: biopharma gains, banking dividends rise, brokerages consolidate and real‑estate shifts—what this means for investors today.

CMS Group’s Q2 outperformed expectations, boosting revenue, margin and investor confidence. Discover how its shift from subsidies to high‑margin, efficient operations is driving sustainable growth and international success.

Explore why the China Media & Entertainment ETF surged on August 25: AI‑short‑form drama, hidden revenue splits, capital risks, and macro‑policy impacts—all revealed through a forensic market lens.